Detalhe da pesquisa
1.
Circulating Tumor DNA as a Predictive Biomarker for Clinical Outcomes With Margetuximab and Pembrolizumab in Pretreated HER2-Positive Gastric/ Gastroesophageal Adenocarcinoma.
Oncology (Williston Park)
; 37(4): 176-183, 2023 04 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37104758
2.
Virtual reality for improving pain and pain-related symptoms in patients with advanced stage colorectal cancer: A pilot trial to test feasibility and acceptability.
Palliat Support Care
; 20(4): 471-481, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35078545
3.
Cabozantinib and Panitumumab for RAS Wild-Type Metastatic Colorectal Cancer.
Oncologist
; 26(6): 465-e917, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33469991
4.
Feasibility, engagement, and acceptability of a behavioral pain management intervention for colorectal cancer survivors with pain and psychological distress: data from a pilot randomized controlled trial.
Support Care Cancer
; 29(9): 5361-5369, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-33686520
5.
Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22-05): a single-arm, phase 1b-2 trial.
Lancet Oncol
; 21(8): 1066-1076, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32653053
6.
Implementation of a Hepatic Artery Infusion Program: Initial Patient Selection and Perioperative Outcomes of Concurrent Hepatic Artery Infusion and Systemic Chemotherapy for Colorectal Liver Metastases.
Ann Surg Oncol
; 27(13): 5086-5095, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32779054
7.
A phase Ib study of capecitabine and ziv-aflibercept followed by a phase II single-arm expansion cohort in chemotherapy refractory metastatic colorectal cancer.
BMC Cancer
; 19(1): 1032, 2019 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31675952
8.
A Phase I Trial of the IGF-1R Antibody Ganitumab (AMG 479) in Combination with Everolimus (RAD001) and Panitumumab in Patients with Advanced Cancer.
Oncologist
; 23(7): 782-790, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29572245
9.
Oxygen for relief of dyspnoea in people with chronic obstructive pulmonary disease who would not qualify for home oxygen: a systematic review and meta-analysis.
Thorax
; 70(5): 492-4, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25472664
10.
Patterns of recurrence after trimodality therapy for esophageal cancer.
Cancer
; 120(14): 2099-105, 2014 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24711267
11.
Phase I study of dasatinib in combination with capecitabine, oxaliplatin and bevacizumab followed by an expanded cohort in previously untreated metastatic colorectal cancer.
Invest New Drugs
; 32(2): 330-9, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24173967
12.
Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumors.
Invest New Drugs
; 32(4): 700-9, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24711126
13.
A phase II study of capecitabine, oxaliplatin, and bevacizumab in the treatment of metastatic esophagogastric adenocarcinomas.
Oncologist
; 18(3): 271-2, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23485624
14.
Hepatic artery infusion for unresectable colorectal cancer liver metastases: Palliation and conversion.
Surgery
; 174(2): 428-430, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37183130
15.
mHealth Coping Skills Training for Symptom Management (mCOPE) for colorectal cancer patients in early to mid-adulthood: Study protocol for a randomized controlled trial.
Contemp Clin Trials Commun
; 33: 101126, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37077935
16.
CT-derived body composition measurements as predictors for neoadjuvant treatment tolerance and survival in gastroesophageal adenocarcinoma.
Abdom Radiol (NY)
; 48(1): 211-219, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36209446
17.
Does preoperative therapy optimize outcomes in patients with resectable pancreatic cancer?
J Surg Oncol
; 106(1): 111-8, 2012 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22311829
18.
A narrative review of the evolving role of immunotherapy in the management of esophageal and gastric cancer.
J Gastrointest Oncol
; 13(4): 2007-2019, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36092313
19.
A phase II trial of bevacizumab plus everolimus for patients with refractory metastatic colorectal cancer.
Oncologist
; 16(8): 1131-7, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21795432
20.
Metastatic Pancreatic Cancer: ASCO Guideline Update.
J Clin Oncol
; 38(27): 3217-3230, 2020 09 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32755482